PubRank

Vera Timmermans-Wielenga

Author PubWeight™ 12.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol Oncol 2009 1.07
2 Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am J Pathol 2010 1.01
3 Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol 2009 0.99
4 Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics 2008 0.95
5 Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res 2010 0.93
6 A common Greenlandic Inuit BRCA1 RING domain founder mutation. Breast Cancer Res Treat 2008 0.92
7 Tumor interstitial fluid - a treasure trove of cancer biomarkers. Biochim Biophys Acta 2013 0.91
8 A single lysis solution for the analysis of tissue samples by different proteomic technologies. Mol Oncol 2008 0.88
9 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol Cell Proteomics 2008 0.88
10 Primary cardiac tumors: a clinicopathologic evaluation of four cases. Cardiovasc Pathol 2010 0.86
11 A high frequent BRCA1 founder mutation identified in the Greenlandic population. Fam Cancer 2009 0.83
12 Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy. Mol Oncol 2010 0.82
13 DNA copy number aberrations in breast cancer by array comparative genomic hybridization. Genomics Proteomics Bioinformatics 2009 0.80
14 Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. Mol Oncol 2007 0.79